I want to go back to the question that my colleague asked you on tamper-proof opioids. One of the clear concerns about this has to do with the so-called balloon effect; that is, if you make tamper-free resistance in one molecule of Oxycontin, that will drive users to other forms like fentanyl.
Isn't the answer to that exactly what the U.S. drug administration has done, which is to make tamper-proof regulations across the entire class of opioids? In terms of not being able to do it, the U.S. has done it and it has resulted in a reduction in opioid deaths, which, as you know, are reaching epidemic proportions across Canada. Why not just make it across the entire class of opioids?